Literature DB >> 10636917

Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix.

A J Reardon1, M Le Goff, M D Briggs, D McLeod, J K Sheehan, D J Thornton, P N Bishop.   

Abstract

A prominent 45-kDa component was identified by protein staining following SDS-polyacrylamide gel electrophoresis of a 4 M guanidine hydrochloride extract from bovine vitreous collagen fibrils. Peptide sequences obtained from this component were used as a basis for the cloning (from human retinal cDNA) and sequencing of a novel member of the leucine-rich repeat extracellular matrix protein family that we have named opticin. Opticin mRNA was found by reverse transcription polymerase chain reaction in ligament and skin as well as in retina. An open reading frame containing 332 amino acids was identified, the first 19 amino acids representing a signal peptide. The deduced amino acid sequence of the mature protein encodes a 35-kDa protein with a calculated isoelectric point of 5.4. The central domain of this protein consists of six B-type leucine-rich repeats. This domain is flanked by cysteine clusters including a C-terminal two-cysteine cluster containing an additional leucine-rich repeat. The N-terminal region contains a cluster of potential O-glycosylation sites, and analysis of bovine vitreous opticin demonstrated the presence of sialylated O-linked oligosaccharides substituting the core protein. Opticin shows highest protein sequence identity to epiphycan (42%) and osteoglycin (35%) and belongs to Class III of the leucine-rich repeat extracellular matrix protein family.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10636917     DOI: 10.1074/jbc.275.3.2123

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Shedding light on a new eye protein.

Authors:  J V Forrester
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

2.  Immunolocalisation of opticin in the human eye.

Authors:  S Ramesh; R E Bonshek; P N Bishop
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

Review 3.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

4.  Retinal Features in Cynomolgus Macaques (Macaca fascicularis) Assessed by Using Scanning Laser Ophthalmoscopy and Spectral Domain Optical Coherence Tomography.

Authors:  Nora Denk; Peter M Maloca; Guido Steiner; Helen Booler; Christian Freichel; Stephanie Niklaus; Tobias K Schnitzer; Pascal W Hasler
Journal:  Comp Med       Date:  2020-03-12       Impact factor: 0.982

5.  Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases.

Authors:  Yuntao Zhang; Xiuli Mao; Tyler Schwend; Stacy Littlechild; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-05       Impact factor: 4.799

Review 6.  Defining the extracellular matrix using proteomics.

Authors:  Adam Byron; Jonathan D Humphries; Martin J Humphries
Journal:  Int J Exp Pathol       Date:  2013-02-19       Impact factor: 1.925

7.  Murine fibromodulin: cDNA and genomic structure, and age-related expression and distribution in the knee joint.

Authors:  A M Säämänen; H J Salminen; A J Rantakokko; D Heinegård; E I Vuorio
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

8.  The vitreous glycoprotein opticin inhibits preretinal neovascularization.

Authors:  Magali M Le Goff; Hongbin Lu; Marta Ugarte; Stephen Henry; Masamine Takanosu; Richard Mayne; Paul N Bishop
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-25       Impact factor: 4.799

Review 9.  A chronic grey matter penumbra, lateral microvascular intussusception and venous peduncular avulsion underlie diabetic vitreous haemorrhage.

Authors:  David McLeod
Journal:  Br J Ophthalmol       Date:  2007-05       Impact factor: 4.638

10.  The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis.

Authors:  Nadia Rucci; Anna Rufo; Marina Alamanou; Mattia Capulli; Andrea Del Fattore; Emma Ahrman; Daria Capece; Valeria Iansante; Francesca Zazzeroni; Edoardo Alesse; Dick Heinegård; Anna Teti
Journal:  J Cell Biol       Date:  2009-11-30       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.